Display options
Share it on

Immunotargets Ther. 2020 Dec 17;9:333-350. doi: 10.2147/ITT.S279228. eCollection 2020.

Acetylcholine Regulates Pulmonary Pathology During Viral Infection and Recovery.

ImmunoTargets and therapy

Alexander P Horkowitz, Ashley V Schwartz, Carlos A Alvarez, Edgar B Herrera, Marilyn L Thoman, Dale A Chatfield, Kent G Osborn, Ralph Feuer, Uduak Z George, Joy A Phillips

Affiliations

  1. Donald P. Shiley Biosciences Center, San Diego State University, San Diego, California, USA.
  2. Department of Biology, San Diego State University, San Diego, California, USA.
  3. Department of Mathematics and Statistics, San Diego State University, San Diego, California, USA.
  4. Department of Chemistry, San Diego State University, San Diego, California, USA.
  5. Office of Animal Research, University of California San Diego, San Diego, California, USA.

PMID: 33365281 PMCID: PMC7751717 DOI: 10.2147/ITT.S279228

Abstract

INTRODUCTION: This study was designed to explore the role of acetylcholine (ACh) in pulmonary viral infection and recovery. Inflammatory control is critical to recovery from respiratory viral infection. ACh secreted from non-neuronal sources, including lymphocytes, plays an important, albeit underappreciated, role in regulating immune-mediated inflammation.

METHODS: ACh and lymphocyte cholinergic status in the lungs were measured over the course of influenza infection and recovery. The role of ACh was examined by inhibiting ACh synthesis in vivo. Pulmonary inflammation was monitored by Iba1 immunofluorescence, using a novel automated algorithm. Tissue repair was monitored histologically.

RESULTS: Pulmonary ACh remained constant through the early stage of infection and increased during the peak of the acquired immune response. As the concentration of ACh increased, cholinergic lymphocytes appeared in the BAL and lungs. Cholinergic capacity was found primarily in CD4 T cells, but also in B cells and CD8 T cells. The cholinergic CD4

CONCLUSION: These findings point to a previously unrecognized role for ACh in the transition from active immunity to recovery and pulmonary repair following respiratory viral infection.

© 2020 Horkowitz et al.

Keywords: Aif-1; CD4 resident memory; ChAT; Iba1; MATLAB; acetylcholine; acetylcholinesterase; automated algorithm; cholinergic anti-inflammatory pathway; cholinergic lymphocytes; inflammaging; inflammation; influenza; pulmonary repair

Conflict of interest statement

This study was supported by NIH AI119929 (JP), San Diego State University Bridge Funding (JP), and San Diego State University Initiative for Maximizing Student Development Award GM058906 (CA). The fun

References

  1. Science. 2019 Feb 8;363(6427):639-644 - PubMed
  2. Immunol Res. 2015 Dec;63(1-3):38-57 - PubMed
  3. Pharmacol Rev. 1978 Mar;30(1):65-132 - PubMed
  4. Epidemiology. 2001 May;12(3):295-7 - PubMed
  5. Genes Brain Behav. 2016 Jan;15(1):89-107 - PubMed
  6. Pharmacol Ther. 2017 Nov;179:1-16 - PubMed
  7. J Pharmacol Exp Ther. 1979 Jul;210(1):91-7 - PubMed
  8. Adv Pharmacol. 2016;76:175-213 - PubMed
  9. Inflamm Res. 2019 Jan;68(1):59-74 - PubMed
  10. Physiol Rev. 2018 Oct 1;98(4):2287-2316 - PubMed
  11. J Neuroimmunol. 2004 Mar;148(1-2):162-71 - PubMed
  12. Am J Respir Cell Mol Biol. 2007 Aug;37(2):186-92 - PubMed
  13. J Neurosci Res. 1996 Apr 01;44(1):66-72 - PubMed
  14. Geriatr Gerontol Int. 2018 Feb;18(2):269-275 - PubMed
  15. Science. 2011 Oct 7;334(6052):98-101 - PubMed
  16. Neurochem Int. 2017 Sep;108:410-416 - PubMed
  17. Proc Natl Acad Sci U S A. 2008 Aug 5;105(31):11008-13 - PubMed
  18. J Immunol. 2011 Dec 1;187(11):5510-4 - PubMed
  19. Alzheimers Dement (N Y). 2019 Jul 10;5:294-302 - PubMed
  20. PLoS One. 2017 Apr 6;12(4):e0175367 - PubMed
  21. Neurosci Lett. 1995 Dec 15;201(3):207-10 - PubMed
  22. Respir Res. 2009 Nov 18;10:112 - PubMed
  23. Biol Lett. 2019 May 31;15(5):20190174 - PubMed
  24. Neurosci Lett. 1989 Oct 9;104(3):336-9 - PubMed
  25. Mucosal Immunol. 2014 May;7(3):501-10 - PubMed
  26. Immun Ageing. 2020 May 7;17:10 - PubMed
  27. Trends Pharmacol Sci. 1990 Jun;11(6):216-9 - PubMed
  28. Med Sci Monit. 2007 Dec;13(12):RA214-21 - PubMed
  29. J Immunol. 2010 Jan 1;184(1):401-10 - PubMed
  30. Proc Natl Acad Sci U S A. 2013 Jan 22;110(4):1410-5 - PubMed
  31. Int Immunopharmacol. 2015 Nov;29(1):127-34 - PubMed
  32. J Neurochem. 2006 Apr;97(2):488-503 - PubMed
  33. Biosci Trends. 2016 Feb;10(1):47-53 - PubMed
  34. Arthritis Rheum. 2006 Aug;54(8):2616-25 - PubMed
  35. Immunology. 2001 Nov;104(3):307-16 - PubMed
  36. Gastroenterology. 2009 Sep;137(3):1029-39, 1039.e1-4 - PubMed
  37. Trends Pharmacol Sci. 2015 Mar;36(3):164-71 - PubMed
  38. Am J Pathol. 2005 Aug;167(2):619-26 - PubMed
  39. Immunity. 2005 Sep;23(3):319-29 - PubMed
  40. Br J Pharmacol. 2006 Jan;147(2):183-7 - PubMed
  41. Radiol Phys Technol. 2019 Jun;12(2):178-184 - PubMed
  42. QJM. 2014 Oct;107(10):789-92 - PubMed
  43. Pharmacol Ther. 2000 Apr;86(1):29-48 - PubMed
  44. Cell Immunol. 2013 Jul-Aug;284(1-2):75-83 - PubMed
  45. Nat Med. 2004 Nov;10(11):1216-21 - PubMed
  46. Exp Gerontol. 2005 Mar;40(3):165-71 - PubMed
  47. PLoS One. 2012;7(7):e40303 - PubMed
  48. Naunyn Schmiedebergs Arch Pharmacol. 1997 Apr;355(4):515-23 - PubMed
  49. Curr Opin Pharmacol. 2014 Jun;16:43-9 - PubMed
  50. Nutr Rev. 2007 Dec;65(12 Pt 2):S173-6 - PubMed
  51. Pharmacol Ther. 2007 Aug;115(2):208-22 - PubMed
  52. Shock. 2007 Dec;28(6):700-3 - PubMed
  53. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3834-8 - PubMed
  54. Proc Natl Acad Sci U S A. 2017 Jul 25;114(30):E6202-E6211 - PubMed
  55. Biochem Biophys Res Commun. 2018 Jan 8;495(2):1901-1907 - PubMed
  56. Cold Spring Harb Symp Quant Biol. 2013;78:259-63 - PubMed
  57. Life Sci. 2012 Nov 27;91(21-22):969-72 - PubMed
  58. Neuroendocrinology. 1998 May;67(5):349-62 - PubMed
  59. Brain Res. 1998 Apr 13;789(2):283-92 - PubMed
  60. J Chromatogr A. 2008 Mar 7;1183(1-2):100-7 - PubMed
  61. J Clin Invest. 2007 Feb;117(2):289-96 - PubMed
  62. Mol Med. 2017 Apr;23:34-39 - PubMed
  63. J Intern Med. 2020 Feb;287(2):120-133 - PubMed
  64. Front Biosci. 2004 Sep 01;9:2063-85 - PubMed
  65. PLoS One. 2015 Mar 27;10(3):e0120441 - PubMed
  66. Life Sci. 2003 Mar 28;72(18-19):2131-4 - PubMed
  67. Clin Vaccine Immunol. 2013 Mar;20(3):319-27 - PubMed
  68. Eur J Pharmacol. 1987 Mar 3;135(1):35-40 - PubMed
  69. Proc Natl Acad Sci U S A. 2005 Apr 5;102(14):5132-7 - PubMed
  70. Front Immunol. 2017 Sep 06;8:1085 - PubMed
  71. J Chromatogr A. 2015 May 22;1395:79-87 - PubMed
  72. Histochem Cell Biol. 2008 Aug;130(2):219-34 - PubMed
  73. J Pharmacol Sci. 2008 Feb;106(2):186-92 - PubMed
  74. JAMA. 1961 Jun 3;176:776-82 - PubMed
  75. J Virol. 2009 Sep;83(18):9356-69 - PubMed
  76. Nature. 2003 Jan 23;421(6921):384-8 - PubMed
  77. J Cardiovasc Transl Res. 2020 Dec;13(6):894-899 - PubMed
  78. FASEB J. 2017 Jan;31(1):320-332 - PubMed
  79. J Immunol. 2005 Nov 15;175(10):6334-43 - PubMed
  80. Trends Immunol. 2019 Feb;40(2):113-127 - PubMed
  81. Crit Care. 2015 Jun 11;19:249 - PubMed
  82. Am J Respir Cell Mol Biol. 1989 Dec;1(6):455-62 - PubMed
  83. J Immunol. 1995 Jan 1;154(1):335-44 - PubMed
  84. J Clin Psychopharmacol. 2018 Apr;38(2):138-143 - PubMed
  85. Physiol Genomics. 2006 Nov 27;27(3):391-7 - PubMed
  86. Pulm Pharmacol Ther. 2001;14(6):423-34 - PubMed
  87. Ann Transl Med. 2017 Jul;5(14):293 - PubMed
  88. Nature. 2000 May 25;405(6785):458-62 - PubMed
  89. Neurosci Lett. 1987 Oct 5;80(3):339-42 - PubMed
  90. Nature. 2020 Jul;583(7816):437-440 - PubMed
  91. Comp Med. 2018 Oct 1;68(5):341-348 - PubMed

Publication Types